首页> 外文期刊>Antimicrobial Resistance and Infection Control >Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014–2016
【24h】

Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014–2016

机译:前往亚洲旅行对携带头孢菌素耐药性大肠杆菌和克雷伯菌属具有很强的预测作用。但并不能解释一切; 2014-2016年在挪威一家医院进行流行病学研究

获取原文
           

摘要

We aimed to estimate the prevalence of faecal carriage of extended-spectrum cephalosporin (ESC) resistant E. coli and K. pneumoniae (ESCr-EK) and vancomycin resistant enterococci (VRE) in patients upon hospital admission and identify factors associated with carriage to better target interventions and to guide empirical antibiotic treatment. Between October 2014 and December 2016, we recruited patients admitted to a Norwegian university hospital. A rectal swab and questionnaire covering possible risk factors for colonisation were collected upon admission. Isolates were characterized by phenotypic methods. ESCr-EK isolates were subject to whole genome sequencing. We calculated prevalence and adjusted prevalence ratios (aPR) using binomial regression. Of 747 patients, 45 (6.0%) were colonised with ESCr-EK, none with VRE. The ESCr-EK isolates in 41 patients were multidrug resistant; no isolates were non-suceptible to meropenem. Prevalence of ESCr-EK was higher among travellers to Asia (aPR?=?6.6; 95%CI 3.6–12; p??0.001). No statistical significant difference in carriage was observed between departments, age or any other factors in the univariable analyses. The observed prevalence of ESCr-EK colonisation upon admission was in the same range but lower than that reported in similar studies from Europe. Travel to Asia was a strong predictor for colonisation of ESCr-EK to be considered when administering empirical antimicrobial treatment. As less than one third of colonised patients had travelled to Asia, and no other factors investigated were found to be strongly associated with carriage, these findings underscore that healthcare personnel must apply standard infection control precautions for all patients.
机译:我们的目的是评估住院患者对大范围头孢菌素(ESC)耐药的大肠杆菌和肺炎克雷伯菌(ESCr-EK)和万古霉素耐药肠球菌(VRE)的粪便携带率,并确定与携带有关的因素,以更好地进行目标干预并指导经验性抗生素治疗。在2014年10月至2016年12月之间,我们招募了一家挪威大学医院的患者。入院时收集直肠拭子和调查表,涵盖可能的定植危险因素。分离物通过表型方法表征。 ESCr-EK分离株经过全基因组测序。我们使用二项式回归计算了患病率并调整了患病率(aPR)。在747例患者中,有45例(6.0%)被ESCr-EK所定植,没有一个被VRE所定植。 41例患者的ESCr-EK分离株具有多重耐药性。没有分离株对美洛培南不敏感。 ESCr-EK的患病率在前往亚洲的旅行者中更高(aPR?=?6.6; 95%CI 3.6-12; p?<?0.001)。在单变量分析中,各部门,年龄或任何其他因素之间在运输方面没有统计学上的显着差异。入院时观察到的ESCr-EK菌落发生率在相同范围内,但低于欧洲类似研究报告的发生率。进行经验性抗菌治疗时,前往亚洲旅行是ESCr-EK定殖的有力预测指标。由于只有不到三分之一的定居患者前往亚洲旅行,而且没有发现与携带有关的其他因素,因此这些发现强调了医护人员必须对所有患者采取标准的感染控制预防措施。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号